7Baggers

We provide you with 20 years of free, institutional-grade data for MRNS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MRNS. Explore the full financial landscape of MRNS stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
NameActionSharesAvg PriceAmountReported Date
MANNING MARTHA ESale-1,894$9.57$18,1262024-02-22
Shafer ChristinaSale-2,153$9.56$20,5832024-02-22
Braunstein ScottSale-11,850$9.94$117,7892024-02-21
Pfanstiel StevenSale-3,092$9.97$30,8272024-02-21
Hulihan JosephSale-2,814$9.98$28,0842024-02-21
Ezickson ElanGrant, award...etc4,6002024-01-19
Fischer Seth H. Z.Grant, award...etc4,6002024-01-19
Nochur SaraGrant, award...etc4,6002024-01-19
Austin CharlesGrant, award...etc4,6002024-01-19
MAYLEBEN TIMOTHY MGrant, award...etc4,6002024-01-19
Shafer ChristinaGrant, award...etc21,8352024-01-19
Pfanstiel StevenGrant, award...etc25,4652024-01-19
MANNING MARTHA EGrant, award...etc21,8352024-01-19
Hulihan JosephGrant, award...etc21,8352024-01-19
Braunstein ScottGrant, award...etc74,6002024-01-19
Silverstein Christine BerniGrant, award...etc4,6002024-01-19
Johnson MarvinGrant, award...etc4,6002024-01-19
Noonberg Sarah B.Grant, award...etc4,6002024-01-19
Shafer ChristinaSale-2,396$9.52$22,8102023-08-08
Braunstein ScottSale-6,443$9.55$61,5312023-08-08
MANNING MARTHA ESale-2,180$9.54$20,7972023-08-08
Pfanstiel StevenSale-2,804$9.54$26,7502023-08-08
Hulihan JosephSale-2,902$9.55$27,7142023-08-08
Noonberg Sarah B.Grant, award...etc7,2002023-05-17
Johnson MarvinGrant, award...etc7,2002023-04-19
Ezickson ElanSale-750$6.56$4,9202023-02-08
Fischer Seth H. Z.Sale-1,018$6.54$6,6582023-02-08
Austin CharlesSale-1,073$6.49$6,9642023-02-08
Hulihan JosephGrant, award...etc25,6482023-01-30
Pfanstiel StevenGrant, award...etc28,1302023-01-30
Braunstein ScottGrant, award...etc80,0002023-01-30
Ezickson ElanGrant, award...etc3,6002023-01-30
Shafer ChristinaGrant, award...etc17,3752023-01-30
Fischer Seth H. Z.Grant, award...etc3,6002023-01-30
MANNING MARTHA EGrant, award...etc16,5482023-01-30
Austin CharlesGrant, award...etc3,6002023-01-30
MAYLEBEN TIMOTHY MGrant, award...etc3,6002023-01-30
Nochur SaraGrant, award...etc3,6002023-01-30
Silverstein Christine BerniGrant, award...etc7,2002023-01-30
Shafer ChristinaSale-1,505$4.7$7,0742022-11-14
Shafer ChristinaInitial2022-06-23
MANNING MARTHA EGrant, award...etc5,7902022-05-26
Braunstein ScottGrant, award...etc19,3052022-05-26
Hulihan JosephGrant, award...etc7,7182022-05-26
Pfanstiel StevenGrant, award...etc7,4482022-05-26
VITULLO NICOLEGrant, award...etc2,7502022-02-07
Pfanstiel StevenGrant, award...etc16,5502022-02-07
Nochur SaraGrant, award...etc2,7502022-02-07
MANNING MARTHA EGrant, award...etc12,8672022-02-07
MAYLEBEN TIMOTHY MGrant, award...etc2,7502022-02-07
Fischer Seth H. Z.Grant, award...etc2,7502022-02-07
Hulihan JosephGrant, award...etc17,1502022-02-07
Ezickson ElanGrant, award...etc2,7502022-02-07
DOUGHERTY MICHAEL RGrant, award...etc2,7502022-02-07
Arroyo SantiagoGrant, award...etc2,7502022-02-07
Braunstein ScottGrant, award...etc42,9002022-02-07
Austin CharlesGrant, award...etc2,7502022-02-07
VITULLO NICOLESale-4,250$15.87$67,4482021-03-16
Smith Edward FSale-40,356$17.8$718,3372021-03-11
Smith Edward FDerivatives Exercise35,9272021-03-11
Login to see more insider transactions
The information provided in this report about MRNS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Marinus Pharmaceuticals, Inc
(NASDAQ:MRNS) 

MRNS stock logo

Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat rare seizure disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in formulations for two routes, including i...

Founded: 2003
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends